Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002074 · ClinicalTrials.gov registry record · NA
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
NCT00002074: Completed NA study, sponsored by Pfizer.
NCT00002074 is a NA study that has completed, run by Pfizer. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002074, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To compare the safety and effectiveness of fluconazole and amphotericin B as maintenance treatment for preventing the relapse of cryptococcal meningitis in patients with AIDS.
Interventions
- DRUG Fluconazole
- DRUG Amphotericin B
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002074 record still lists
NCT00002074 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Fluconazole is the first listed.
NCT00002074 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002074 about?
NCT00002074 is a clinical study titled "Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome". To compare the safety and effectiveness of fluconazole and amphotericin B as maintenance treatment for preventing the relapse of cryptococcal meningitis in patients with AIDS.
What is the current status of trial NCT00002074?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002074?
The interventions under investigation include: Fluconazole (DRUG), Amphotericin B (DRUG).
Who is sponsoring clinical trial NCT00002074?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.